# AHN-12 Biodistribution in Advanced Leukemia

> **NCT01207076** · PHASE1 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 8 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Acute Lymphoblastic Leukemia
- Chronic Myelogenous Leukemia

## Interventions

- **BIOLOGICAL:** 90Y-AHN-12

## Key facts

- **NCT ID:** NCT01207076
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207076, "AHN-12 Biodistribution in Advanced Leukemia". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01207076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*